Congresses
This is the logo of the provider
Amsterdam ,  Netherlands 7 - 10 May 2025

European Association for the Study of the Liver Congress (EASL 2025)

Presentation schedule and materials
Wednesday, 07 May 2025
08:30  - 16:00
CEST
LBP-019
POSTER
Semaglutide-treated participants in the phase 3 ESSENCE trial (part 1) have greater concordance of non-invasive test improvements compared with placebo
Mary E. Rinella1; Manal F. Abdelmalek2; Elisabetta Bugianesi3; Anna M.G. Calí4; Laurent Castera5,6; Kristiane A. Engebretsen4; Jacob George7; Wah Kheong Chan8; Niels Krarup4; Michelle T. Long4; Philip Newsome9,10; Cláudia P. Oliveira11; Georgios Papatheodoridis12; Ahsan Shoeb4; Salvatore Petta13; Michael Roden14,15,16; Arun J. Sanyal17; Yusuf Yilmaz18; Vlad Ratziu19; on behalf of the ESSENCE Study Group
MATERIALS AVAILABLE
easl2025_essence_nits_treatment_slides
Slide
snna2518_easl25_essencenit_treat
Poster
Thursday, 08 May 2025
12:45  - 13:45
CEST
Symposium
Updates on the essence of MASH
Elizabeth Powell ;  Philip Newsome ;  Faiez Zannad ;  Steven E. Kahn
MATERIALS AVAILABLE
easl_2025_teaser-video_updates-on-the-essence-of-mash
Teaser Video
summary_infographic_easl_congress2025_updates_on_the_essence_of_mash
Infographic
Saturday, 10 May 2025
11:45  - 12:45
CEST
Symposium
Personalised management of MASH
Jörn M. Schattenberg ;  Alina M. Allen ;  Jean-Francois Dufour
MATERIALS AVAILABLE
easl_2025_teaser-video_personalised-management-of-mash
Teaser Video
summary_infographic_easl_symposium_2025_personalised_management_of_mash
Infographic
Keywords
MASH
EASL